有機合成薬品工業（4531） – Summary of Financial Results for the third quarter 2022

Non-Consolidated Financial Results for the Nine Months Ended December 31, 2021 [Japanese GAAP] January 31, 2022 Company name: YUKI GOSEI KOGYO CO., LTD. Stock exchange listing: Tokyo Stock Exchange Code number: 4531 URL: https://www.yuki-gosei.co.jp/ Representative: Seiichiro Matsumoto, President Contact: Yasuhiko Yamato, Director and Senior Managing Executive Officer Phone: +81-3-3664-3980 Scheduled date of filing quarterly securities report: February 10, 2022 Scheduled date of commencing dividend payments: — Availability of supplementary briefing material on quarterly financial results: No Schedule of quarterly financial results briefing session: No 1. Non-Consolidated Financial Results for the Nine Months Ended December 31, 2021 (April 1, 2021 to (Amounts of less than one million yen are rounded down.) December 31, 2021) (1) Non-Consolidated Operating Results Nine months ended December 31, 2021 December 31, 2020 Million yen 8,367 7,411 Net sales (% indicates changes from the previous corresponding period.) Operating income Ordinary income Net income % Million yen 378 (62) 12.9 (7.5) % Million yen 357 – (82) – % Million yen 216 – 72 – % 196.6 (15.5) Net income per share Diluted net income Yen – – Yen 9.90 3.34 per share Nine months ended December 31, 2021 December 31, 2020 (2) Non-Consolidated Financial Position As of December 31, 2021 As of March 31, 2021 (Reference) Equity: As of December 31, 2021: ¥10,923 million 2. Dividends As of March 31, 2021: ¥10,946 million Million yen 21,354 20,998 Total assets Million yen 10,923 10,946 Net assets Equity ratio % 51.2 52.1 1st quarter-end Yen – – 2nd quarter-end Yen 0.00 0.00 Annual dividends 3rd quarter-end Yen – – Fiscal year ended March 31, 2021 Fiscal year ending March 31, 2022 Fiscal year ending March 31, 2022 (Forecast) (Note) Revision to the forecast for dividends announced most recently: No Year-end Total Yen 3.00 3.00 Yen 3.00 3.00 1 3. Non-Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2022 (April 1, 2021 to March 31, 2022) (% indicates changes from the previous corresponding period.) Net sales Operating income Ordinary income Net income Net income per share Million yen 12,000 % Million yen % Million yen % Million yen 8.2 Full year (Note) Revision to the financial results forecast announced most recently: No * Notes: (1) Accounting policies adopted specially for the preparation of quarterly non-consolidated financial statements: Yes 330 87.0 360 64.4 % 180 (37.6) Yen 8.24 (2) Changes in accounting policies, changes in accounting estimates and retrospective restatement 1) Changes in accounting policies due to the revision of accounting standards: Yes 2) Changes in accounting policies other than 1) above: No 3) Changes in accounting estimates: No 4) Retrospective restatement: No (3) Total number of issued shares (common shares) 1) Total number of issued shares at the end of the period (including treasury shares): December 31, 2021: March 31, 2021: 21,974,000 shares 21,974,000 shares 2) Total number of treasury shares at the end of the period: December 31, 2021: March 31, 2021: 148,900 shares 148,424 shares 3) Average number of shares during the period: Nine months ended December 31, 2021: Nine months ended December 31, 2020: 21,825,373 shares 21,826,174 shares * These non-consolidated financial results are outside the scope of quarterly review procedures conducted by a certified public accountant or an audit firm. * Explanation of the proper use of financial results forecast and other notes The earnings forecasts and other forward-looking statements herein are based on information that is available and certain assumptions deemed reasonable as of the date of publication of this document. Actual results may differ significantly from these forecasts due to a wide range of factors. Regarding the assumptions that the financial results forecast is based on, and notes with regard to the usage of the financial results forecast, please refer to Page 3 of the attachment of this document Non-Consolidated Financial Results for the Nine Months Ended December 31, 2021 (available in Japanese only). 2